Symposium, Access, Medicine, COVID, Coronavirus, NYU, Prescription, Drugs, Government, Healthcare, Insurance, Research, Pharmaceutical, Pharma, NIH, Pandemic, Vaccine, Patent, Generic, Pay-For-Delay, Reverse-Payment, Settlement, Intellectual Property, IP, Licensing, Public Health, Biomedical, Bioeth
R&D, property rights, outsourcing, cannibalization, innovation, vertical integration
This is a National Bureau of Economic Research Paper. NBER charges a fee of
$5.00 for this paper.
File name: nber.pdf
If you wish to purchase the right to make copies of this paper for distribution to others, please select the quantity.
cash prices, price transparency, cost savings, simulations, imaging, private insurer
readmission penalties, geo-demographics, hospital ownership, case mix index, health information technology
This page was processed by aws-apollo5 in 0.373 seconds